Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,715 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NLRP3, a potential therapeutic target for type 2 diabetes?
Liu SS, Ding Y, Lou JQ. Liu SS, et al. Among authors: ding y. Cardiovasc Drugs Ther. 2014 Aug;28(4):391-2. doi: 10.1007/s10557-014-6531-z. Cardiovasc Drugs Ther. 2014. PMID: 24867817 No abstract available.
MBL, a potential therapeutic target for type 1 diabetes?
Liu SS, Lou JQ, Ding Y. Liu SS, et al. Among authors: ding y. Mol Immunol. 2015 Feb;63(2):603. doi: 10.1016/j.molimm.2014.07.022. Epub 2014 Aug 22. Mol Immunol. 2015. PMID: 25155995 No abstract available.
First-in-human study on tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of XKH001, a recombinant humanized monoclonal antibody against IL-25 in healthy Chinese volunteers.
Zhang H, Zheng W, Peng R, Wu D, Hu Y, Sun T, Gao L, Liu Y, Guo L, Ding Y, Liu L. Zhang H, et al. Among authors: ding y. Expert Opin Investig Drugs. 2025 Jan 15. doi: 10.1080/13543784.2025.2453162. Online ahead of print. Expert Opin Investig Drugs. 2025. PMID: 39815604
21,715 results
You have reached the last available page of results. Please see the User Guide for more information.